Tela Bio Inc
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. Show More...
-
Website https://www.telabio.com
-
Sector Healthcare
-
Industry Medical Devices
-
Last Quote 1.39 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -4.2 -4.61 -17.1 -2.58 Dividends USD Payout Ratio % * Shares Mil 6.0 6.0 2.0 11.0 Book Value Per Share * USD -14.06 2.12 Free Cash Flow Per Share * USD -2.66 Return on Assets % -175.3 -99.8 -63.5 -50.03 Financial Leverage (Average) 2.19 2.43 Return on Equity % -121.5 Return on Invested Capital % -47.36 Interest Coverage -3.68 -10.7 -5.21 -5.62 Current Ratio 2.33 2.43 9.58 13.07 Quick Ratio 1.97 1.94 8.55 11.52 Debt/Equity 0.98 1.25